Abstract
A population-based cohort study was conducted in Shanghai, China, to investigate the relationship between family cancer history in first-degree relatives and risk of breast cancer. A total of 570 newly diagnosed breast cancer patients were identified from the cohort of 73,222 women during the follow-up period. Breast cancer risk was elevated (RR = 1.74, 95% CI: 1.10–2.73) for those with a family history of breast cancer and the risk was stronger for women who were younger than 55 years (RR = 2.07, 95% CI: 1.17–3.64). In addition, a significantly increased risk was observed for women with a family history of leukemia (RR = 2.06; 95% CI: 1.02–4.15) and among younger women, those who reported having a family history of any cancer (RR = 1.41, 95% CI: 1.10–1.82), lung cancer (RR = 1.72, 95% CI: 1.12–2.65), and esophageal cancer (RR = 2.99, 95% CI: 1.62–5.51). This cohort study suggests that, as previously observed in high risk populations, family history plays an important role in breast cancer also in a low risk population. The link between breast cancer risk and family history of cancers of the lung and esophagus, as well as leukemia, warrants further investigation.
Similar content being viewed by others
References
Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005) Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 117:655–661. doi:10.1002/ijc.21236
Ambrosone CB, Marshall JR, Vena JE, Laughlin R, Graham S, Nemoto T, Freudenheim JL (1995) Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk. New York, United States. Cancer Causes Control 6:407–415
American Cancer Society (ed) (2006) Breast cancer facts and figures: 2005–2006. ACS, Atlanta, GA
Anderson H, Bladstrom A, Olsson H, Moller TR (2000) Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol 152:1154–1163. doi:10.1093/aje/152.12.1154
Brignone G, Cusimano R, Dardanoni G, Gugliuzza M, Lanzarone F, Scibilia V, Dardanoni L (1987) A case–control study on breast cancer risk factors in a southern European population. Int J Epidemiol 16:356–361
Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN (1995) Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87:827–835
Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L (2003) Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 106:96–102. doi:10.1002/ijc.11186
Claus EB, Stowe M, Carter D (2003) Family history of breast and ovarian cancer and the risk of breast carcinoma in situ. Breast Cancer Res Treat 78:7–15. doi:10.1023/A:1022147920262
Collaborative Group C. in Breast (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58, 209 women with breast cancer and 101, 986 women without the disease. [see comment]. Lancet 358:1389–1399. doi:10.1016/S0140-6736(01)06524-2
Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr (2001) Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 93:148–152. doi:10.1002/ijc.1294
Easton DF (2002) Familial risks of breast cancer. Breast Cancer Res 4:179–181. doi:10.1186/bcr448
Eeles RA, Stratton MR, Goldgar DE, Easton DF (1994) The genetics of familial breast cancer and their practical implications. Eur J Cancer 30A:1383–1390. doi:10.1016/0959-8049(94)90190-2
Garavello W, Negri E, Talamini R, Levi F, Zambon P, Dal Maso L, Bosetti C, Franceschi S, La Vecchia C (2005) Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomarkers Prev 14:1390–1393. doi:10.1158/1055-9965.EPI-04-0911
Gardner KM, Ou Shu X, Jin F, Dai Q, Ruan Z, Thompson SJ, Hussey JR, Gao YT, Zheng W (2002) Occupations and breast cancer risk among Chinese women in urban Shanghai. Am J Ind Med 42:296–308. doi:10.1002/ajim.10112
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608. doi:10.1093/jnci/86.21.1600
Hemminki K, Czene K (2002) Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 11:1638–1644
Hemminki K, Granstrom C (2003) Familial breast cancer: scope for more susceptibility genes? Breast Cancer Res Treat 82:17–22. doi:10.1023/B:BREA.0000003871.38587.8b
Hemminki K, Granstrom C, Czene K (2002) Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden. [see comment]. Int J Cancer 100:214–219. doi:10.1002/ijc.10467
Hiatt RA, Bawol R, Friedman GD, Hoover R (1984) Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer 54:139–144
IARC (2002) Cancer incidence in five continents, vol VIII. IARC, Lyon
John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, West DW, Whittemore AS (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 24:2869–2876. doi:10.1001/jama.298.24.2869
Li R, Gilliland FD, Baumgartner KB, Samet J (2001) Family history and risk of breast cancer in hispanic and non-hispanic women: the New Mexico Women’s Health Study. Cancer Causes Control 12:747–753. doi:10.1023/A:1011285205870
Malander S, Ridderheim M, Masback A, Loman N, Kristoffersson U, Olsson H, Nilbert M, Borg A (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40:422–428. doi:10.1016/j.ejca.2003.09.016
Malkin D (1993) p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet 66:83–92. doi:10.1016/0165-4608(93)90233-C
Mayne ST, Buenconsejo J, Janerich DT (1999) Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidemiol Biomarkers Prev 8:1065–1069
McCredie M, Paul C, Skegg DC, Williams S (1997) Family history and risk of breast cancer in New Zealand. Int J Cancer 73:503–507. doi:10.1002/(SICI)1097-0215(19971114)73:4<503::AID-IJC8>3.0.CO;2-3
Nomura AM, Kolonel LN, Hirohata T, Lee J (1986) The association of replacement estrogens with breast cancer. Int J Cancer 37:49–53
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800–809. doi:10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
Rauscher GH, Sandler DP, Poole C, Pankow J, Mitchell B, Bloomfield CD, Olshan AF (2002) Family history of cancer and incidence of acute leukemia in adults. Am J Epidemiol 156:517–526. doi:10.1093/aje/kwf075
Rawal R, Bertelsen L, Olsen JH (2006) Cancer incidence in first-degree relatives of a population-based set of cases of early-onset breast cancer. Eur J Cancer 42:3034–3040. doi:10.1016/j.ejca.2006.04.025
Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–710. doi:10.1086/318787
Rookus MA, van Leeuwen FE (1994) Oral contraceptives and risk of breast cancer in women aged 20–54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group [see comment]. Lancet 344:844–851
Shannon J, Ray R, Wu C, Nelson Z, Gao DL, Li W, Hu W, Lampe J, Horner N, Satia J, Patterson R, Fitzgibbons D, Porter P, Thomas D (2005) Food and botanical groupings and risk of breast cancer: a case–control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 14:81–90
Siskind V, Schofield F, Rice D, Bain C (1989) Breast cancer and breastfeeding: results from an Australian case–control study. Am J Epidemiol 130:229–236
Slattery ML, Kerber RA (1993) A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database see comment. JAMA 270:1563–1568. doi:10.1001/jama.270.13.1563
Sng JH, Chang J, Feroze F (2000) The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 82:538–542. doi:10.1054/bjoc.1999.0960
Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia [see comment]. N Engl J Med 325:1831–1836
White E, Malone KE, Weiss NS, Daling JR (1994) Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst 86:505–514
Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Correa P (1996) Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States [see comment].Am J Epidemiol 143:535–542
Yang L, Parkin DM, Li L et al (2003) Time trends in cancer mortality in China: 1987–1999. Int J Cancer 106:771–783. doi:10.1002/ijc.11300
Zheng W, Chow W-H, Yang G, Jin F, Rothman N, Blair A, Li H-L, Wen W, Ji B-T, Li Q, Shu X-O, Gao Y-T (2005) The Shanghai Women’s Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 162:1123–1131. doi:10.1093/aje/kwi322
Acknowledgment
This research was supported by National Institutes of Health research grant R01 CA70867 and by Intramural Research Program contract N02 CP1101066. The authors express their appreciation to Shanghai residents who participated in the study and thank the research staff of the Shanghai Women’s Health Study for their dedication and hard work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kilfoy, B.A., Zhang, Y., Shu, XO. et al. Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women’s health study. Cancer Causes Control 19, 1139–1145 (2008). https://doi.org/10.1007/s10552-008-9181-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9181-2